** J.P.Morgan upgrades beauty and skincare firm Bath & Body Works BBWI.N to "overweight" from "neutral", citing potential for revenue growth in FY25
** Brokerage sees BBWI's "three-legged stool" of product innovation, marketing and technology supporting growth within its "core" categories of home fragrance, body care, and hand soaps/sanitizers
** J.P.Morgan raises target price to $47 from $41, representing a ~29% upside from last close
** Brokerage says, "We see sales growth and therefore fixed cost leverage as the primary driver to bridge operating margins to management's ~20% long-term target"
** 13 of 19 brokerages rate the stock "buy" or higher, 5 "hold" and 1 "sell" or lower; their median PT is $45
** Up to last close, BBWI stock which fell 10% in 2024, was down 6% YTD in 2025
(Reporting by Kanchana Chakravarty in Bengaluru)
((Kanchana.Chakravarty@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。